封面
市場調查報告書
商品編碼
1310846

神經行銷解決方案市場:按技術、最終用途行業分類 - COVID-19、俄羅斯-烏克蘭衝突、高累積的累積影響 - 2023-2030 年全球預測

Neuromarketing Solution Market by Technology, End Use Industry - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

神經行銷解決方案的全球市場預計到 2023 年將達到 15.8108 億美元,年複合成長率為 10.80%,預計到 2030 年將出現驚人的成長,達到 32.456 億美元。

FPNV定位矩陣

FPNV 定位矩陣對於評估全球神經行銷解決方案市場至關重要。透過檢驗業務策略和產品滿意度等關鍵指標,它可以對供應商進行全面評估,使用戶能夠根據自己的特定需求做出資訊的決策。這種進階分析將供應商分為四個像限,並取得了不同程度的成功:前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對整體收入、客戶群和其他關鍵指標的貢獻,可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解:

1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。

2. 市場開發:提供有關利潤豐厚的新興市場的詳細資訊,並分析其在成熟市場的滲透率。

3. 市場多元化:提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢:全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題:

1. 神經行銷解決方案的全球市場規模和預測是多少?

2.在預測期內,COVID-19 對全球神經行銷解決方案市場的阻礙因素和影響為何?

3. 在預測期內,全球神經行銷解決方案市場需要投資哪些產品/細分市場/應用/領域?

4. 全球神經行銷解決方案市場的競爭策略是什麼?

5. 全球神經行銷解決方案市場的技術趨勢和法律規範是什麼?

6. 全球神經行銷解決方案市場主要供應商的市場佔有率是多少?

7. 哪些型態和策略舉措被認為適合進入神經行銷解決方案的全球市場?

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 根據優點申請的可能性,例如有效且有效率的行銷策略和活動
      • 分析消費者購買行為的需求日益成長
      • 更多採用生物辨識、fMRI 和 GSR 等尖端技術
    • 抑制因素
      • 需要相對較高的成本
    • 機會
      • 眼動追蹤解決方案和廣告研究的新用途
      • 持續研究並開發具有成本效益的解決方案
    • 任務
      • 嚴格的法規協議
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 神經行銷解決方案市場:依技術分類

  • 腦電圖測試
  • 眼球追蹤
  • 功能性磁振造影
  • 腦磁圖
  • 正子斷層掃描

第7章 最終用途產業的神經行銷解決方案市場

  • 銀行金融服務和保險
  • 市場調查
  • 零售/消費品牌
  • 科學機構

第8章 美洲神經行銷解決方案市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太神經行銷解決方案市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲神經行銷解決方案市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析:主要企業
  • 競爭情境分析:主要企業

第12章上市公司名單

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-036C5CF3B4D1

The Global Neuromarketing Solution Market is forecasted to grow significantly, with a projected USD 1,581.08 million in 2023 at a CAGR of 10.80% and expected to reach a staggering USD 3,245.60 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Neuromarketing Solution Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Neuromarketing Solution Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Technology, market is studied across Electroencephalography, Eye Tracking, Functional Magnetic Resonance Imaging, Magnetoencephalographic, and Positron Emission Tomography. The Functional Magnetic Resonance Imaging is projected to witness significant market share during forecast period.

Based on End Use Industry, market is studied across Banking Financial Services, and Insurance, Market Research, Retail/Consumer Brands, and Scientific Institutions. The Market Research is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Neuromarketing Solution Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Neuromarketing Solution Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neuromarketing Solution Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neuromarketing Solution Market?

4. What is the competitive strategic window for opportunities in the Global Neuromarketing Solution Market?

5. What are the technology trends and regulatory frameworks in the Global Neuromarketing Solution Market?

6. What is the market share of the leading vendors in the Global Neuromarketing Solution Market?

7. What modes and strategic moves are considered suitable for entering the Global Neuromarketing Solution Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Neuromarketing Solution Market, by Technology, 2022 vs 2030
  • 4.3. Neuromarketing Solution Market, by End Use Industry, 2022 vs 2030
  • 4.4. Neuromarketing Solution Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Potential application attributed to benefits such as effective and efficient marketing strategies and campaigns
      • 5.1.1.2. Growing need to analyze consumer buying behavior
      • 5.1.1.3. Rising adoption of cutting-edge technology such as biometrics, fMRI, and GSR
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost required
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging use of eye-tracking solutions and advertising research
      • 5.1.3.2. Ongoing research and development toward cost-effective solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory protocols
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Neuromarketing Solution Market, by Technology

  • 6.1. Introduction
  • 6.2. Electroencephalography
  • 6.3. Eye Tracking
  • 6.4. Functional Magnetic Resonance Imaging
  • 6.5. Magnetoencephalographic
  • 6.6. Positron Emission Tomography

7. Neuromarketing Solution Market, by End Use Industry

  • 7.1. Introduction
  • 7.2. Banking Financial Services, and Insurance
  • 7.3. Market Research
  • 7.4. Retail/Consumer Brands
  • 7.5. Scientific Institutions

8. Americas Neuromarketing Solution Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Neuromarketing Solution Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Neuromarketing Solution Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NEUROMARKETING SOLUTION MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROMARKETING SOLUTION MARKET SIZE, 2022 VS 2030
  • FIGURE 3. NEUROMARKETING SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 5. NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2022 VS 2030 (%)
  • FIGURE 6. NEUROMARKETING SOLUTION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. NEUROMARKETING SOLUTION MARKET DYNAMICS
  • FIGURE 8. NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NEUROMARKETING SOLUTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES NEUROMARKETING SOLUTION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC NEUROMARKETING SOLUTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA NEUROMARKETING SOLUTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. NEUROMARKETING SOLUTION MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. NEUROMARKETING SOLUTION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. NEUROMARKETING SOLUTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. NEUROMARKETING SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 5. NEUROMARKETING SOLUTION MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROMARKETING SOLUTION MARKET SIZE, BY EYE TRACKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NEUROMARKETING SOLUTION MARKET SIZE, BY FUNCTIONAL MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NEUROMARKETING SOLUTION MARKET SIZE, BY MAGNETOENCEPHALOGRAPHIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NEUROMARKETING SOLUTION MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 11. NEUROMARKETING SOLUTION MARKET SIZE, BY BANKING FINANCIAL SERVICES, AND INSURANCE , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NEUROMARKETING SOLUTION MARKET SIZE, BY MARKET RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NEUROMARKETING SOLUTION MARKET SIZE, BY RETAIL/CONSUMER BRANDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NEUROMARKETING SOLUTION MARKET SIZE, BY SCIENTIFIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS NEUROMARKETING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES NEUROMARKETING SOLUTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC NEUROMARKETING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA NEUROMARKETING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM NEUROMARKETING SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM NEUROMARKETING SOLUTION MARKET SIZE, BY END USE INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 101. NEUROMARKETING SOLUTION MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 102. NEUROMARKETING SOLUTION MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 103. NEUROMARKETING SOLUTION MARKET LICENSE & PRICING